IntelGenx (TSXV:IGX,OTCQX:IGXT) confirmed that its cannabis-infused oral film, VersaFilm, is on track to be released commercially in Q1 2020.
As quoted in the press release:
IntelGenx announced that a cannabis-infused VersaFilm® product has been finalized with its co-development partner, Tilray, and all manufacturing scale-up work has been successfully completed.
“Because we believe this is an exciting product that will meet, if not exceed, consumer expectations, we think that we’re well positioned to become a significant player in this expanding market as new product formats come online,” commented Dr. Horst G. Zerbe, CEO of IntelGenx. “We continue to work with Health Canada in the pursuit of our requisite micro-processing license – the last step before commercial production can commence.”